1. Home
  2. ANPA vs TIL Comparison

ANPA vs TIL Comparison

Compare ANPA & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rich Sparkle Holdings Limited Ordinary Shares

ANPA

Rich Sparkle Holdings Limited Ordinary Shares

N/A

Current Price

$1.16

Market Cap

47.0M

Sector

N/A

ML Signal

N/A

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

N/A

Current Price

$6.06

Market Cap

52.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANPA
TIL
Founded
2016
2018
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.0M
52.2M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
ANPA
TIL
Price
$1.16
$6.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.1K
★ 66.1K
Earning Date
09-30-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.06
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.14
$5.56
52 Week High
$180.64
$14.54

Technical Indicators

Market Signals
Indicator
ANPA
TIL
Relative Strength Index (RSI) 26.46 40.46
Support Level N/A $5.56
Resistance Level $2.18 $7.67
Average True Range (ATR) 0.10 0.51
MACD 0.02 -0.01
Stochastic Oscillator 11.34 31.95

Price Performance

Historical Comparison
ANPA
TIL

About ANPA Rich Sparkle Holdings Limited Ordinary Shares

Rich Sparkle Holdings Ltd is a holding company conducting its operations as a professional specialist in the provision of financial printing services such as printing, typesetting and translation, advisory services including Environmental, Social and Governance (ESG) and internal control reporting services and other services including standalone annual general meeting and extraordinary general meeting supporting service and other standalone services, through its sole operating subsidiary in Hong Kong. Its segments include Financial printing services such as printing, typesetting and translation, Advisory services including Environmental, Social and Governance Report and Other services.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: